1. Home
  2. IMRN vs SGMA Comparison

IMRN vs SGMA Comparison

Compare IMRN & SGMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • SGMA
  • Stock Information
  • Founded
  • IMRN 1994
  • SGMA 1993
  • Country
  • IMRN Australia
  • SGMA United States
  • Employees
  • IMRN N/A
  • SGMA N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • SGMA Electrical Products
  • Sector
  • IMRN Health Care
  • SGMA Technology
  • Exchange
  • IMRN Nasdaq
  • SGMA Nasdaq
  • Market Cap
  • IMRN 15.0M
  • SGMA 16.1M
  • IPO Year
  • IMRN N/A
  • SGMA 1994
  • Fundamental
  • Price
  • IMRN $2.20
  • SGMA $2.97
  • Analyst Decision
  • IMRN Strong Buy
  • SGMA
  • Analyst Count
  • IMRN 1
  • SGMA 0
  • Target Price
  • IMRN $5.00
  • SGMA N/A
  • AVG Volume (30 Days)
  • IMRN 6.6K
  • SGMA 27.6K
  • Earning Date
  • IMRN 10-22-2024
  • SGMA 09-19-2024
  • Dividend Yield
  • IMRN N/A
  • SGMA N/A
  • EPS Growth
  • IMRN N/A
  • SGMA N/A
  • EPS
  • IMRN N/A
  • SGMA N/A
  • Revenue
  • IMRN $3,271,194.00
  • SGMA $360,530,443.00
  • Revenue This Year
  • IMRN N/A
  • SGMA N/A
  • Revenue Next Year
  • IMRN N/A
  • SGMA N/A
  • P/E Ratio
  • IMRN N/A
  • SGMA N/A
  • Revenue Growth
  • IMRN 171.67
  • SGMA N/A
  • 52 Week Low
  • IMRN $1.48
  • SGMA $2.27
  • 52 Week High
  • IMRN $5.96
  • SGMA $6.47
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 29.63
  • SGMA 53.13
  • Support Level
  • IMRN $2.66
  • SGMA $2.80
  • Resistance Level
  • IMRN $2.87
  • SGMA $3.21
  • Average True Range (ATR)
  • IMRN 0.14
  • SGMA 0.20
  • MACD
  • IMRN -0.06
  • SGMA 0.06
  • Stochastic Oscillator
  • IMRN 1.50
  • SGMA 67.19

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

Share on Social Networks: